The reference cell line (as above) from ATCC turned turbid on D3 upon thawing. I managed to salvage the cells with 2500U/mL of Penicillin/streptomycin. The bacterial culture from supernatant showed presence of pseudomonas fluorescens.
Following 7 days of high dose antibiotic exposure, I have been growing the surviving cells in antibiotic free media for the past 4 weeks. First in 96 well plate then in 6 well plates. Of the 54 wells (6 well plates), 3 well showed residual infection and were discarded. The remaining wells do not show signs of infection; clear media. The cells appeared fine and are dividing (some are forming aggregates). But after three weeks the cells are seen sparcely scattered in a space less than 20% of the plate area, spread only at a single plane. The cells are grown in ATCC recommended media as stated in the product insert: RPMI1640 (Gibco) + FBS10% (Gibco) + 0.05mM BME. The doubling time is suppose to be 3-4 days.
My initial impression was that the surviving cells could be having low clonogenic properties. Until I stumbled upon the patent for H929 as available at http://www.google.com.mx/patents/US4892829
Under Material & Methods > In summary > the following statement was identified:
'It is noted that the use of a serum free defined medium was critical for culture establishment, as the tumor cells initially failed to proliferate in serum containing media.'
Nevertheless, I have found numerous research articles which had used serum containing media for H929 culture.
Is the slow growth:
Expected for cell lines recovering from infection?
Is it because of the media formulation? [The complete media sustained rapid K562 growth indicating that the FBS is not faulty]
Has anyone experience similar situation with NCI-H929?